A new type of profile control agent - MaDG

被引:0
|
作者
Southwest Petroleum University, Chengdu 610500, China [1 ]
机构
来源
Xinan Shiyou Xueyuan Xuebao | 2006年 / 4卷 / 74-77期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] A new voltage profile perception and control method in active distribution network applying multi-agent technology
    Liu K.
    Luo C.
    Tao S.
    Jia D.
    Sheng W.
    1600, Power System Technology Press (40): : 2106 - 2112
  • [32] Pharmacological profile of CCP 48506, a new positive inotropic agent
    Neumann, J
    Scholz, H
    Zimmermann, N
    CARDIOVASCULAR DRUG REVIEWS, 1997, 15 (02): : 174 - 186
  • [33] A SYMPOSIUM - BEVANTOLOL - A NEW CARDIOVASCULAR AGENT WITH A UNIQUE PROFILE - DISCUSSION
    TAYLOR
    KAPLAN
    VERDOUW
    RAFTERY
    CAMPESE
    FAIRHURST
    BOWLES
    SALONEN
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (12): : E41 - E42
  • [34] ASSESSMENT OF THE ANTIARRHYTHMIC PROFILE OF THE NEW CLASS I AGENT DIPRAFENONE
    GULKER, H
    THALE, J
    OLBING, B
    HEUER, H
    FRENKING, B
    BENDER, F
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-2 (09): : 1387 - 1393
  • [35] A SYMPOSIUM - BEVANTOLOL - A NEW CARDIOVASCULAR AGENT WITH A UNIQUE PROFILE - INTRODUCTION
    TAYLOR, SH
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (12): : E1 - E2
  • [36] PHARMACO-EEG PROFILE OF A NEW HYPNOTIC AGENT - ZOLPIDEM
    DEPOORTERE, H
    DECOBERT, M
    GRANGER, P
    RIOUMERLE, F
    JOURNAL DE PHARMACOLOGIE, 1986, 17 (03) : 386 - 386
  • [37] IMMUNOLOGICAL PROFILE OF DL111-IT, A NEW IMMUNOSUPPRESSANT AGENT
    MISTRELLO, G
    GALLIANI, G
    ASSANDRI, A
    FILIPPESCHI, S
    BASSI, L
    IMMUNOPHARMACOLOGY, 1985, 10 (03): : 163 - 169
  • [38] THE PHARMACOLOGIC PROFILE OF NABILONE - A NEW ANTI-EMETIC AGENT
    STARK, P
    CANCER TREATMENT REVIEWS, 1982, 9 : 11 - 16
  • [39] Pharmacokinetic/pharmacodynamic profile for tigecycline - a new glycylcycline antimicrobial agent
    Meagher, AK
    Ambrose, PG
    Grasela, TH
    Ellis-Grosse, EJ
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) : 165 - 171
  • [40] PHARMACOLOGICAL PROFILE OF TAZASUBRATE, A NEW CHOLESTEROL-LOWERING AGENT
    SCHULZE, E
    OBERMAIER, J
    SEYFRIED, CA
    DIEKMANN, HW
    NOWAK, H
    ATHEROSCLEROSIS, 1986, 59 (02) : 137 - 145